Larry Biegelsen
Stock Analyst at Wells Fargo
(1.8)
# 1157
Out of 5,329 analysts
336
Total ratings
52.49%
Success rate
10.55%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BLCO Bausch & Lomb | Maintains: Equal-Weight | 15 12 | 11.55 | 3.9% | 6 | May 1, 2025 | |
GEHC GE HealthCare Techs | Maintains: Overweight | 103 89 | 67.71 | 31.44% | 4 | May 1, 2025 | |
TNDM Tandem Diabetes Care | Maintains: Equal-Weight | 22 20 | 19.99 | 0.05% | 9 | May 1, 2025 | |
GKOS Glaukos | Downgrades: Equal-Weight | 160 86 | 83.11 | 3.48% | 14 | May 1, 2025 | |
PEN Penumbra | Maintains: Overweight | 305 315 | 291.69 | 7.99% | 18 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 22 17 | 15.04 | 13.03% | 12 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 28 | 22.98 | 21.85% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 2 | 0.73 | 76.71% | 4 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 214 146 | 126.55 | 15.37% | 4 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 120 117 | 93.28 | 25.43% | 8 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 198 195 | 158.05 | 23.38% | 11 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 100 118 | 103.16 | 14.39% | 12 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 13 17 | 11.8 | 44.07% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 427 435 | 374.51 | 16.15% | 14 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 630 687 | 517.45 | 32.77% | 19 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 166 152 | 154.43 | -1.57% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 65 80 | n/a | n/a | 6 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 10 8 | 3.77 | 112.2% | 6 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 90 94 | 70.19 | 33.92% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 115 118 | 81.21 | 45.3% | 16 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 106 98 | 83.44 | 17.45% | 17 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 110 117 | 101.89 | 14.83% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 90 80 | 75.33 | 6.2% | 15 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 94 105 | 96.25 | 9.09% | 8 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 44 40 | 30.63 | 30.59% | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 42 40 | 17.98 | 122.47% | 17 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 17 14 | n/a | n/a | 11 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 200 210 | n/a | n/a | 6 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 68 71 | n/a | n/a | 6 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 40 49 | 16.45 | 197.87% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 140 136 | 131 | 3.82% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 80 70 | 71.08 | -1.52% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 62 | n/a | n/a | 6 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 279 270 | 169.54 | 59.25% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Apr 25, 2017 |